DERMAREN
LIVE

Serial Number

79438295

Owner

ACMEDI KOREA Co., Ltd.

Attorney

Michael Feldenkrais

Filing Date

Oct 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DERMAREN Trademark

Serial Number: 79438295

DERMAREN is a trademark filed by ACMEDI KOREA Co., Ltd. on October 2, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

ACMEDI KOREA Co., Ltd. (3 trademarks)

#611,612-1, 293, Mokdongdong-ro,

Entity Type: 03

Trademark Details

Filing Date

October 2, 2025

Registration Date

Not Registered

Published for Opposition

July 14, 2026

Goods & Services

Medical tissue activating gels for subcutaneous injection for wrinkle reduction; Medical hyaluronic acid injectable dermal fillers for skin hydration and wrinkle treatment; Medical ampoules sold filled with hyaluronic acid derivatives and mixtures with other polysaccharides, with lidocaine and without lidocaine for medical purposes.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2026 TROA
REFUSAL PROCESSED BY IB
May 7, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 17, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 11, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 10, 2026 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 6, 2026 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 6, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 5, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2025 REPR